|
Market Closed -
Nasdaq
04:00:00 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 535.38 USD | +1.15% |
|
-3.53% | -20.86% |
| Aug. 17 | IDEXX Laboratories, Inc. - Analyst/Investor Day | |
| Aug. 11 | IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.15% | -3.53% | -8.45% | -4.76% | -20.86% | -16.74% | +7.94% | -22.22% | +369.26% | 42.18B | |
| Average | +1.15% | -2.90% | -8.45% | -4.76% | -20.86% | -16.74% | +7.94% | -22.22% | +369.26% | 42.18B | |
| Weighted average by Cap. | +1.15% | -2.90% | -8.45% | -4.76% | -20.86% | -16.74% | +7.94% | -22.22% | +369.26% |
- Stock Market
- Stocks
- IDXX Stock
- Sector IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
